🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will compare dalbavancin to standard of care (SOC) antibiotic th...
Status
Terminated
Location
Midway Immunology and Research Center
Start Date
2017-05-12
Trial ID
NCT03148756
Treatments Being Tested
This is a Phase 2b clinical study, multicenter, randomized, open-label, ass...
Status
Completed
Location
University of Alabama Hospital - Infectious Diseases
Start Date
2021-04-22
Trial ID
NCT04775953
Treatments Being Tested
This study will evaluate a new critical pathway (use of guideline-based pat...
Status
Completed
Location
Maricopa Medical Center
Start Date
2016-11-29
Trial ID
NCT02961764
Treatments Being Tested
This clinical study will be a multi-center, randomized, open-label, active-...
Status
Terminated
Location
Midway Immunology and Research Center
Start Date
2017-05-15
Trial ID
NCT03091439
Treatments Being Tested
Adolescent subjects hospitalized for the treatment of bacterial infections ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-09
Trial ID
NCT00678106
Treatments Being Tested
Dalbavancin for Pediatric Osteomyelitis...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-03
Trial ID
NCT02344511
Treatments Being Tested
This study will compare the effectiveness of two different treatments for p...
Status
Recruiting
Location
University of Colorado Denver Anschutz Medical Campus
Start Date
2024-03-01
Trial ID
NCT06266494
Treatments Being Tested
This study will be a double-blind, randomized, multicenter trial to assess ...
Status
Withdrawn
Location
Mercury Street Medical Group
Start Date
2015-11
Trial ID
NCT02269644
Treatments Being Tested
The purpose of this research is to determine if a new antibiotic called dal...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-04
Trial ID
NCT03982030
Treatments Being Tested
This study will evaluate the pharmacokinetic properties of dalbavancin when...
Status
Completed
Location
University of Colorado Hospital
Start Date
2017-05-01
Trial ID
NCT02940730
Treatments Being Tested